Jio, Airtel Lose Subscribers In July As BSNL Gains: TRAI
Reliance Jio Infocomm Ltd., Bharti Airtel Ltd. and Vodafone Idea Ltd. lost subscribers in the month of July while BSNL Ltd. or Bharat Sanchar Nigam added subscribers, according to the Telecom Regulatory Authority of India.
Reliance Jio lost 7.58 lakh subscribers whereas BSNL added 29.3 lakh subscribers in July. Bharti Airtel lost 16.9 lakh users and Vodafone Idea lost 14.1 lakh users.
Vodafone Idea's wireless subscriber base fell to 12.672 crore.
"The total broadband subscribers increased from 94.07 crore at the end of June to 94.61 crore at the end of July with a monthly growth rate of 0.58%," TRAI said in a release.
The release also said that the private access service providers held 92.25% market share of the wireless subscribers whereas BSNL and MTNL, the two public sector access service providers, had a market share of only 7.75%.
The number of Machine-To-Machine cellular mobile connections increased from 5.25 crore at the end of June to 5.36 crore at the end of July.
M2M cellular mobile connections are used for devices to exchange information over cellular networks. Unlike traditional SIM cards, M2M SIM cards can switch networks dynamically and provide global connectivity.
Bharti Airtel holds the highest number of M2M cellular mobile connections at 2.84 crore, with a market share of 53.02%, followed by Vodafone Idea (27.71%), Reliance Jio (13.68%), and BSNL (5.58%).
In July, a total of 1.36 crore requests were received for Mobile Number Portability, which is a service that allows users to retain their phone numbers when switching to a different mobile network operator.
Cumulative MNP requests increased from 99.74 crore at the end of June to 101.113 crore at the end of July.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets